The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Juluca for HIV Now in Pharmacies

by The GoodRx Pharmacist on December 29, 2017 at 2:24 pm

Complicated multi-pill regimens are treatments of the past for many chronic health issues, and HIV is no exception. Pharmaceutical companies are realizing that more is not better and are developing less complex treatments to increase patient adherence.   

On November 21st the FDA approved Juluca, the first two-drug regimen for certain patients with HIV, and it is now available in pharmacies.

What Juluca indicated for?

Juluca is a two-drug combination medication indicated as a complete regimen for the treatment of HIV-1 infection in adults. It is intended to replace the current antiretroviral regimen for those who are virologically suppressed for at least six months with no history of treatment failure.

Is there anything unique about Juluca?

Yes. Juluca is the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment.  

Are there any side effects associated with Juluca?

The most common side effects include diarrhea and headache. More serious side effects include skin rash, allergic reactions, liver problems, depression, and mood changes.

For more information on Juluca, see the press release from Viiv Healthcare.


Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.